OTC Markets Group Welcomes New OTCQB Companies - January 8Press Release | 01/08/2020

OTC Markets Group Inc.(OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following company is approved for trading on the OTCQB Venture Market:

Avivagen, Inc.(TSX-V: VIV; OTCQB: VIVXF) Avivagen is developing and commercializing products that promote health in animals and humans. The Corporation's unique OxC-beta technology is a proprietary, first-in-class source of B-carotene-oxygen copolymer compounds that confer a variety of non-vitamin A health benefits. These benefits have wide, global utility, including replacement of antibiotics in livestock feeds, as well as for food-production conditions where antibiotics cannot be used, and supporting good health in companion animals.

U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for this company onwww.otcmarkets.com.

About OTC Markets Group Inc.

OTC Markets Group Inc.(OTCQX: OTCM) operates the OTCQX Best Market, the OTCQB Venture Market and the Pink Open Market for 10,000 U.S. and global securities. Through OTC Link ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.

OTC Markets, OTCQX, OTCQB, Pink and OTC Link are registered trademarks of OTC Markets Group Inc.

Subscribe to the OTC Markets RSS Feed

Attachments

  • Original document
  • Permalink

Disclaimer

OTC Markets Group Inc. published this content on 08 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 January 2020 15:42:07 UTC